BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8074257)

  • 1. Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys.
    Collins WE; Galland GG; Sullivan JS; Morris CL
    Am J Trop Med Hyg; 1994 Aug; 51(2):224-32. PubMed ID: 8074257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
    Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of Peruvian Aotus nancymai monkeys with different strains of Plasmodium falciparum, P. vivax, and P. malariae.
    Collins WE; Skinner JC; Pappaioanou M; Broderson JR; Ma NS; Filipski V; Stanfill PS; Rogers L
    J Parasitol; 1988 Jun; 74(3):392-8. PubMed ID: 3288739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
    Darko CA; Angov E; Collins WE; Bergmann-Leitner ES; Girouard AS; Hitt SL; McBride JS; Diggs CL; Holder AA; Long CA; Barnwell JW; Lyon JA
    Infect Immun; 2005 Jan; 73(1):287-97. PubMed ID: 15618165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys.
    Collins WE; Galland GG; Barnwell JW; Udhayakumar V; Sullivan JS; Nace D; Tongren JE; Williams T; Roberts J; Shi YP; Lal AA
    Am J Trop Med Hyg; 2005 Oct; 73(4):686-93. PubMed ID: 16222010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation of a strain of Plasmodium falciparum from Ghana to Aotus lemurinus griseimembra, A. nancymai, and A. vociferans monkeys.
    Sullivan JS; Sullivan JJ; Williams A; Grady KK; Bounngaseng A; Huber CS; Nace D; Williams T; Galland GG; Barnwell JW; Collins WE
    Am J Trop Med Hyg; 2003 Dec; 69(6):593-600. PubMed ID: 14740874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on the Vietnam Palo Alto strain of Plasmodium vivax in two species of Aotus monkeys.
    Collins WE; Sullivan JS; Galland GG; Williams A; Nace D; Williams T; Barnwell JW
    J Parasitol; 2005 Apr; 91(2):461-3. PubMed ID: 15986626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of the Panama strain of Plasmodium vivax for the testing of malarial vaccines in Aotus nancymai monkeys.
    Collins WE; Sullivan JS; Galland GG; Williams A; Nace D; Williams T
    Am J Trop Med Hyg; 2002 Nov; 67(5):454-8. PubMed ID: 12479543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.
    Hisaeda H; Saul A; Reece JJ; Kennedy MC; Long CA; Miller LH; Stowers AW
    J Infect Dis; 2002 Mar; 185(5):657-64. PubMed ID: 11865423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of Plasmodium vivax to growth in owl monkeys (Aotus nancymai).
    Williams AM; Barefield SJ; Carter ER; Collins WE; Sullivan JS; Tate MK
    Comp Med; 2005 Dec; 55(6):528-32. PubMed ID: 16422149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated infection of Aotus monkeys with Plasmodium falciparum induces protection against subsequent challenge with homologous and heterologous strains of parasite.
    Jones TR; Obaldia N; Gramzinski RA; Hoffman SL
    Am J Trop Med Hyg; 2000 Jun; 62(6):675-80. PubMed ID: 11304053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum infection of splenectomized and intact Guyanan Saimiri monkeys.
    Pye D; O'Brien CM; Franchina P; Monger C; Anders RF
    J Parasitol; 1994 Aug; 80(4):558-62. PubMed ID: 8064523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of falciparum malaria infection on the in vitro mitogen responses of spleen and peripheral blood lymphocytes from owl monkeys.
    Taylor DW; Siddiqui WA
    Am J Trop Med Hyg; 1978 Jul; 27(4):738-42. PubMed ID: 99058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.
    Stowers AW; Cioce V; Shimp RL; Lawson M; Hui G; Muratova O; Kaslow DC; Robinson R; Long CA; Miller LH
    Infect Immun; 2001 Mar; 69(3):1536-46. PubMed ID: 11179324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys.
    De SL; Stanisic DI; van Breda K; Bellete B; Harris I; McCallum F; Edstein MD; Good MF
    Int J Parasitol; 2016 Aug; 46(9):581-91. PubMed ID: 27238088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO; Keegan B; Long CA; Miller LH
    J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Santa Lucia strain of Plasmodium falciparum as a model for vaccine studies. II. Development of Aotus vociferans as a model for testing transmission-blocking vaccines.
    Collins WE; Galland GG; Sullivan JS; Morris CL; Richardson BB
    Am J Trop Med Hyg; 1996 Apr; 54(4):380-5. PubMed ID: 8615451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.